Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Adial Pharmaceuticals (ADIL) Total Liabilities (2022 - 2024)

Adial Pharmaceuticals' Total Liabilities history spans 3 years, with the latest figure at $829046.0 for Q3 2024.

  • For Q3 2024, Total Liabilities rose 56.96% year-over-year to $829046.0; the TTM value through Sep 2024 reached $829046.0, up 56.96%, while the annual FY2023 figure was $653076.0, 73.41% down from the prior year.
  • Total Liabilities for Q3 2024 was $829046.0 at Adial Pharmaceuticals, up from $671882.0 in the prior quarter.
  • Across five years, Total Liabilities topped out at $3.3 million in Q1 2022 and bottomed at $461752.0 in Q2 2023.
  • The 3-year median for Total Liabilities is $829046.0 (2024), against an average of $1.6 million.
  • The largest annual shift saw Total Liabilities crashed 84.41% in 2023 before it surged 56.96% in 2024.
  • A 3-year view of Total Liabilities shows it stood at $2.5 million in 2022, then tumbled by 73.41% to $653076.0 in 2023, then rose by 26.94% to $829046.0 in 2024.
  • Per Business Quant, the three most recent readings for ADIL's Total Liabilities are $829046.0 (Q3 2024), $671882.0 (Q2 2024), and $562731.0 (Q1 2024).